Epana

Epana Bio

This company develops precision T-cell engagers and biologics using artificial intelligence and genomics to treat patients with autoimmune diseases.

Graph Therapeutics

This company develops artificial intelligence technology to create targeted therapies and biomarkers for patients with immune-mediated diseases.

Regcell

This biotechnology company develops regulatory T-cell therapies using an epigenetic reprogramming platform to treat patients with autoimmune diseases and inflammatory conditions.

Egle Therapeutics

This biotechnology company develops precision medicines that modulate regulatory T cells to treat patients with autoimmune diseases and cancer.

EpiBiologics

This company develops bispecific antibodies to degrade extracellular proteins for patients with cancer and autoimmune disorders.

Modulus Therapeutics

This company develops engineered NK-cell therapies for autoimmune disease patients using a generative design and rapid prototyping platform.

Epics Therapeutics

This biotechnology company develops small-molecule RNA epigenetic modulators to treat patients with solid tumours and autoimmune diseases.

Ditto Biosciences

The company develops parasite-derived protein therapies for pharmaceutical and biotechnology partners to treat patients with autoimmune diseases using an artificial intelligence platform.